STLN
Starling Oncology, Inc. Health Care Services-Offices & Clinics of Doctors of Medicine Russell 3000
$6.53Close
$645.6MMarket cap
$2.38 – $7.0552-week range
Nov 5, 2026Next report · after the close
Highlights
Strengths
- In a stage-2 uptrend all 8 trend conditions pass
- Leading the market RS 95 · stronger than 95% of stocks over 12 months
Cautions
- Results soon Nov 5, 2026, in 4 days
- Financial distress Altman Z″ in the distress zone
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
7%
1wk
down 2.7%
price change
1mo
up 3.3%
price change
12-month return
up 42%
market up 11% ·
its own up 28%
F-score
—
— Not assessed
Altman Z″
-5.27
Elevated risk
P/E
0.0×
price / earnings
PEG
—
P/E / EPS growth
P/B
—
price / book
Earnings yield
down 5.2%
EBIT / enterprise value
Cheaper than
12%
of the market · expensive
Revenue growth
up 28%
year on year
EPS growth
—
latest quarter
Sales growth
up 35%
latest quarter · -7 pts
ROE
—
return on equity
Free cash margin
down 6%
-$27.8M FCF
D/E
—
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Piotroski tests
Repair signals
- Long-term debt down 17% ($0.1B → $0.1B)
Trade setup
ATR%
5.7%
$0.37 a day · 2×ATR $5.79
RS
95 / 99
vs the universe
Trend
8 / 8
trend template
Relative volume
1.1×
vs 50-day average
Up/down volume
1.00
50 sessions
Implied move
—
no option chain · report Nov 5, 2026
Trend template · 8 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- Liabilities exceed assets Shareholders' equity is negative at -$15.7M as of Dec 31, 2025. What is left for shareholders after creditors is, on the balance sheet, less than nothing.
- Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
- Shareholders diluted The share count rose 30.5% over the year, from 76m to 99m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
- Profit not backed by cash Reported profit of $60.6B came with -$24.6M of operating cash flow. Profit that cash does not follow is the classic signature of aggressive accounting.
Last reported
Aug 6, 2026
Results reaction
Aug 6, 2026+27% vs market2 sessions after results
Financials
- Net 12055%
- Free cash -6%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $187.5M | $203.0M | $252.5M | $324.2M | $393.4M | $502.7M |
| Operating income | -$8.2M | -$45.9M | -$82.0M | -$77.0M | -$60.1M | -$36.1M |
| Net income | -$14.3M | -$10.9M | $152,000 | -$83.1M | $64.7B | $60.6B |
| Net margin | -8% | -5% | 0% | -26% | 16436% | 12055% |
| Earnings per share | -$0.24 | -$0.16 | $0.00 | -$1.13 | $861.67 | $655.98 |
| Free cash flow | -$686,000 | -$35.5M | -$67.3M | -$40.9M | -$30.3M | -$27.8M |
| Free cash margin | -0% | -18% | -27% | -13% | -8% | -6% |
| Cash | $900,000 | $115.2M | $14.0M | $33.5M | $49.7M | $33.6M |
| Long-term debt | $6.6M | $0 | $80.6M | $86.8M | $93.1M | $77.4M |
| Shareholders' equity | $28.1M | $104.2M | $123.2M | $57.0M | $3.6M | -$15.7M |
| Shares outstanding | 23m | 73.25m | 73.27m | 74.15m | 75.74m | 98.86m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 6, 2026 | Quarterly ↗ | Jun 30, 2026 | 37d |
| May 7, 2026 | Quarterly ↗ | Mar 31, 2026 | 37d |
| Mar 12, 2026 | Annual ↗ | Dec 31, 2025 | 71d |
| Nov 13, 2025 | Quarterly ↗ | Sep 30, 2025 | 44d |
| Aug 13, 2025 | Quarterly ↗ | Jun 30, 2025 | 44d |
| May 14, 2025 | Quarterly ↗ | Mar 31, 2025 | 44d |
| Mar 26, 2025 | Annual ↗ | Dec 31, 2024 | 85d |
| Nov 13, 2024 | Quarterly ↗ | Sep 30, 2024 | 44d |
| Aug 13, 2024 | Quarterly ↗ | Jun 30, 2024 | 44d |
| May 14, 2024 | Quarterly ↗ | Mar 31, 2024 | 44d |
| Mar 28, 2024 | Annual ↗ | Dec 31, 2023 | 88d |
| Nov 8, 2023 | Quarterly ↗ | Sep 30, 2023 | 39d |
Current reports
| Filed | Disclosed |
|---|---|
| Sep 2, 2026 | Director or officer change ↗ |
| Aug 21, 2026 | Material agreement · New obligation ↗ |
| Aug 6, 2026 | Results ↗ |
| Aug 3, 2026 | Charter or bylaws · Regulation FD ↗ |
| Jul 7, 2026 | Material agreement · New obligation · Unregistered share sale · Regulation FD ↗ |
| Jun 18, 2026 | Shareholder vote ↗ |
| May 22, 2026 | Cybersecurity incident ↗ |
| May 7, 2026 | Results ↗ |
| Mar 13, 2026 | Regulation FD ↗ |
| Mar 12, 2026 | Results ↗ |
| Feb 23, 2026 | Director or officer change · Regulation FD ↗ |
| Jan 12, 2026 | Results ↗ |